Illness Severity and Work Productivity Loss Among Working Adults With Medically Attended Acute Respiratory Illnesses: US Influenza Vaccine Effectiveness Network 2012-2013
- PMID: 26565004
- PMCID: PMC4725387
- DOI: 10.1093/cid/civ952
Illness Severity and Work Productivity Loss Among Working Adults With Medically Attended Acute Respiratory Illnesses: US Influenza Vaccine Effectiveness Network 2012-2013
Abstract
Background: Influenza causes significant morbidity and mortality, with considerable economic costs, including lost work productivity. Influenza vaccines may reduce the economic burden through primary prevention of influenza and reduction in illness severity.
Methods: We examined illness severity and work productivity loss among working adults with medically attended acute respiratory illnesses and compared outcomes for subjects with and without laboratory-confirmed influenza and by influenza vaccination status among subjects with influenza during the 2012-2013 influenza season.
Results: Illnesses laboratory-confirmed as influenza (ie, cases) were subjectively assessed as more severe than illnesses not caused by influenza (ie, noncases) based on multiple measures, including current health status at study enrollment (≤7 days from illness onset) and current activity and sleep quality status relative to usual. Influenza cases reported missing 45% more work hours (20.5 vs 15.0; P < .001) than noncases and subjectively assessed their work productivity as impeded to a greater degree (6.0 vs 5.4; P < .001). Current health status and current activity relative to usual were subjectively assessed as modestly but significantly better for vaccinated cases compared with unvaccinated cases; however, no significant modifications of sleep quality, missed work hours, or work productivity loss were noted for vaccinated subjects.
Conclusions: Influenza illnesses were more severe and resulted in more missed work hours and productivity loss than illnesses not confirmed as influenza. Modest reductions in illness severity for vaccinated cases were observed. These findings highlight the burden of influenza illnesses and illustrate the importance of laboratory confirmation of influenza outcomes in evaluations of vaccine effectiveness.
Keywords: illness severity; medically attended acute respiratory illness; medically attended influenza; vaccine effectiveness; work productivity.
© The Author 2015. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.
Figures
Similar articles
-
Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015.MMWR Morb Mortal Wkly Rep. 2015 Jan 16;64(1):10-5. MMWR Morb Mortal Wkly Rep. 2015. PMID: 25590680 Free PMC article.
-
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.JAMA. 1999 Jul 14;282(2):137-44. doi: 10.1001/jama.282.2.137. JAMA. 1999. PMID: 10411194 Clinical Trial.
-
Early estimates of seasonal influenza vaccine effectiveness--United States, January 2013.MMWR Morb Mortal Wkly Rep. 2013 Jan 18;62(2):32-5. MMWR Morb Mortal Wkly Rep. 2013. PMID: 23325354 Free PMC article.
-
Contribution of influenza viruses to medically attended acute respiratory illnesses in children in high-income countries: a meta-analysis.Influenza Other Respir Viruses. 2016 Nov;10(6):444-454. doi: 10.1111/irv.12400. Epub 2016 Aug 18. Influenza Other Respir Viruses. 2016. PMID: 27311404 Free PMC article. Review.
-
Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults.Drugs. 2011 Aug 20;71(12):1591-622. doi: 10.2165/11206860-000000000-00000. Drugs. 2011. PMID: 21861544 Review.
Cited by
-
Work Attendance with Acute Respiratory Illness Before and During COVID-19 Pandemic, United States, 2018-2022.Emerg Infect Dis. 2023 Dec;29(12):2442-2450. doi: 10.3201/eid2912.231070. Epub 2023 Nov 12. Emerg Infect Dis. 2023. PMID: 37917142 Free PMC article.
-
Impact of Influenza and Influenza-Like Illness on Work Productivity Outcomes: A Systematic Literature Review.Pharmacoeconomics. 2023 Mar;41(3):253-273. doi: 10.1007/s40273-022-01224-9. Epub 2022 Dec 14. Pharmacoeconomics. 2023. PMID: 36515814 Free PMC article.
-
Vaccine-associated attenuation of subjective severity among outpatients with influenza.Vaccine. 2022 Jul 30;40(32):4322-4327. doi: 10.1016/j.vaccine.2022.06.019. Epub 2022 Jun 14. Vaccine. 2022. PMID: 35710506 Free PMC article.
-
Prevalence and Predictors of Persistent Symptoms After Clearance of SARS-CoV-2 Infection: A Multicenter Study from Egypt.Infect Drug Resist. 2022 May 20;15:2575-2587. doi: 10.2147/IDR.S355064. eCollection 2022. Infect Drug Resist. 2022. PMID: 35619736 Free PMC article.
-
The economic burden of influenza among adults aged 18 to 64: A systematic literature review.Influenza Other Respir Viruses. 2022 May;16(3):376-385. doi: 10.1111/irv.12963. Epub 2022 Feb 5. Influenza Other Respir Viruses. 2022. PMID: 35122389 Free PMC article. Review.
References
-
- Thompson MG, Shay DK, Zhou H et al. . Updated estimates of mortality associated with seasonal influenza through the 2006–2007 influenza season. MMWR Morb Mortal Wkly Rep 2010; 59:1057–62. - PubMed
-
- Thompson WW, Shay DK, Weintraub E et al. . Influenza-associated hospitalizations in the United States. JAMA 2004; 292:1333–40. - PubMed
-
- Molinari NAM, Ortega-Sanchez IR, Messonnier ML et al. . The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007; 25:5086–96. - PubMed
-
- Palmer LA, Rousculp MD, Johnston SS, Mahadevia PJ, Nichol KL. Effect of influenza-like illness and other wintertime respiratory illnesses on worker productivity: the Child and Household Influenza-Illness and Employee Function (CHIEF) study. Vaccine 2010; 32:453–7. - PubMed
-
- Nichol KL, D'Heilly SJ, Greenberg ME, Ehlinger E. Burden of influenza-like illness and effectiveness of influenza vaccination among working adults aged 50–64 years. Clin Infect Dis 2009; 48:292–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical

